News & Updates

New drug applications approved by US FDA as of 01 - 15 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A large number of cancer survivors and patients fear disease recurrence, reports a recent meta-analysis. Healthcare providers should address this issue with their patients and be ready to recommend interventions when needed.

Men take into consideration both personal and medical factors when deciding to continue active surveillance, reports a recent study.

In childhood cancer survivors (CCS), treatment with vincristine appears to be linked with global longitudinal strain (GLS) abnormalities over the long-term, a new study has found.

Selective internal radiation therapy (SIRT) with resin yttrium-90 microspheres followed by standard chemotherapy is feasible and effective in patients with unresectable intrahepatic cholangiocarcinoma (ICC), a phase II single-arm study in Hong Kong, Singapore and Thailand has shown.